DAFTAR PUSTAKA

Ana C, Manuel, Rebelo LP, Lemos JPA, Barbosa ML. Association between the
level of quality of life and nutritional status in patients undergoing chronic
renal hemodialysis. J Bras Nefrol. 2013; 35(4): 279-288.

Anonim, 2010, National Chronic Kidney Disease Fact Sheet 2010, Department of
Health & Human Service USA, CDC.

Anonim, 2013a, The United satates Renal Data System (USRDS),

http://www.usrds.org, 25 November 2014.

Arora, P., Varelli, M, 2010. Chronic Renal Failure. Available from:

http://emedicine.medscape.com/article/238798-overview

Bakta, I.M., 2006, Pendekatan Terhadap Pasien Anemia dalam Buku Ajar Ilmu
Penyakit Dalam, Edisi Keempat, Pusat Penerbitan Departemen Ilmu
Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, Jakarta.

Belaiche, S., Romanet, T., Allenet, B., Calop, I., Zaqui, P., 2012, Identification of
Drug-Related Problems in Ambulatory Chronic Kidney Disease Patients: a
to Month Prospective Study. Jour Nephrol, Feb,8:0

Brown, L.J., Clark, P.C., Amstrong, K.A., Lipiry, Z.Z., Duhbar, S.B., 2010,
Identification of Modifiable Chronic Kidney Disease Risk Factor by
Gender in an African-American Metabolic Syndrome Cohort. Nephrol
Nurse J; 37(2):133-143.

Brunner. L., Suddarth, D,2002, Buku Ajar Keperawatan Medikal

Bedah,1,EGC:Jakarta.

Cibulka. R., Racek. J.,2007,Metabolic disorders in patients with chronic kidney

failure. Institute of clinical biochemistry and hematology Charles
university. Faculty of medicine and faculty hospital in pilsen; 56: 697-705.

Cipolle, R.J., Strand, L.M., Morley. P.C., (1998). Pharmaceutical Care Practice.
New York. Mc Graw-Hill.

Coresh. J., Selvin. E., Stevens. LA., et al,Prevalence of chronic kidney disease in
the United States, Jama-Journal of the American Medical Association
2007;298:2038–2047.

Donnelly. S,2001,Why is erythropoietin made in the kidney? The kidney functions

as a critmeter. Am J Kidney Dis; 38:415–425.

68
Dalton, C., & Schmidt, R., 2008, Diagnosis and Treatment of Anemia of Chronic
Kidney Disease in the Primary Care Setting, dalam The Journal for Nurse
Practitoners-JNP, hal 194-199.

Foote, E. F., & Manley, H. J.,2008, Hemodialysis and Peritoneal Dialysis. In J. T.

DiPiro, R. L. Talbert, G. C. Yee, G. R. Matzke, B. G. Wells & L. M. Posey
(Eds.), Pharmacotherapy A Pathophysiologic Approach (Seventh ed., pp.
793-810). New York: The McGraw-Hill Companies.
Grabe,D.W., Low, C.L., Bailie, G.R., Eisele, G., 1997, Evaluation of Drug-
Related Problems in an Outpatient Hemodialysis Unit and Impact of a
Clinical Pharmacist, Clin Nephrol, 47(2):115-121
Hudson, J.Q., Chaudhary, K., 2005, Therapeutic Approach for The Management
of Complication, dalam Dipiro, J.T., 6 th, Pharmacotherapy
APathophysiologic Approach, 826-833, Apleton and Large., Philadelphia.

Irawati. Y,2010,Kajian DRPs Pada Penatalaksanaan Pasien Hemodialisis di

RSAL DR. Ramelan Surabaya,Tesis, Universitas Gadjah
Mada:Yogyakarta.

Joy, M.S., Kshirsagar, A., Paparello, J., 2005, Chronic Kidney Disease:
Progression, Modifying, Therapies dalam Dipiro, J.T., Talbert, R.L., Yee,
G.C., Maltzke, G.R., Wells, B.C., Posey, L.M., Pharmacotherapy A
Pathopysiologic Approach, 6th Ed, 895, Appeton and Lange:Philadelphia.

Junaidi MA. Status indeks massa tubuh pasien penyakit ginjal kronik yang
menjalani hemodialisis di rumah sakit Cipto Mangunkusumo pada bulan
Februari 2009 dan korelasinya dengan lama menjalani
hemodialisis.Skripsi. Fakultas Kedokteran Universitas Indonesia; 2009.

KDOQI, 2002, Clinical Practice Guidelines For Chronic Kidney

Disease:Evaluation, Classification and Stratification, National Kidney
Foundation.

Khasanah, R.H.,2011, Kajian DRPs Pasien Hemodialisis Ruin di RS PKU

Muhammadiyah Yogyakarta Periode Mei-Juli 2011,Tesis,Universitas
Gadjah Mada:Yogyakarta.

Koda – Kimbel, M.A., Yee, Y.L., Brian, A.K., Robin, C.L., Joseph, G.B., Wayne,
K.A., Bradley, W.R., 2009, Applied Therapeutics; The Clinical Use of
Drugs, 9th Ed,Appeton and Lange:Philadelphia.

Lacy, C.F., Amstrong, L.L., Goldman, M.P., Lance, L.L., 2009, Drug Information
Handbook, 14th Ed, AphA, Lexi-Comp Inc, Hudson: Ohio.

69
Lankhorst, C.E., Wish, J.B., 2010, Anemia in Renal Disease: Diagnosis
andManagement, Blood Reviews.,24, 39–47.

Lau, A.H., 2005, Glomerolunephritis, dalam Dipiro, J,T., Talbert, R.L., Yee, G.L.,
Matzke, G.R., Wells, R.G., Posey, L.M., (Eds), Pharmacotheraphy A
Pathophysiologic Approach, 6th Ed,895, Appetton and Lange:Philadelphia.

Marsden, PA., MD.,2009,Treatment of Anemia in Chronic Kidney Disease-

Strategies Based on Evidence. N Engl J Med ; 361 : 2089-2090.
Mason, B.J., Ineck, B., Lyons, W., 2008, Anemias, dalam Dipiro, J.T., Talbert,
R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, .M.,Pharmacotherapy
A Pathophysiologi Approach, 7th Edition, The McGraw-Hill Companies
Inc., USA.

Mikhail, A., Shrivastava, R., Richardson, D., 2012, Clinical Practice Guidelines
Anaemia of Chronic Kidney Disease, UK Renal Association, 5th Ed.

National Kidney Foundation (NKF), 2002. KDOQI Clinical Practice Guidelines

for Chronic Kidney Disease: Evaluation, Classification, and Stratification.
http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p2_background
.htm

National Kidney Foundation. IV. NKF-K/DOQI Clinical Practice Guidelines for

Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001;
37(suppl 1):182–238.
National Kidney Foundation: K/DOQI, 2006, Clinical Practice Guidelines and
Clinical Practice Recommendations for Anemia in Chronic Kidney
Disease;47(5):3.

Nurko. S,2006,Anemia in chronic kidney disease : Causes, diagnosis, treatment.

Cleveland Clinic Journal pf Medicine,73 : 289-297

Perazella, M.A., 2005. Chronic Kidney Disease. In: Reilly, R.F, Jr., Perazella,
M.A., ed. Nephrology In 30 Days. New York: Mc Graw Hill, 251-274.

Persatuan Nefrologi Indonesia (PERNEFRI), 2001, Konsensus:

ManajemenAnemia Pada Pasien Penyakit ginjal kronik, Jakarta.

Perhimpunan Nefrologi Indonesia,2011,Pengkajian Status Besi dan Terapi Besi.

Konsensus Manajemen Anemia Pada Penyakit Ginjal Kronik. Ed II : 11-
16

Pharmaceutical Care Network Europe Foundation, 2006, PCNE Classification for

drug-related problems. Pharmaceutical care research.V5.01.

70
Prince, S & Wilson, L, 2005. Patofisiologi: Konsep Klinis Proses-
ProsesPenyakit.Edisi 6. EGC, Jakarta.

Rahardjo, P., Susalit, E., Suhardjono., 2006. Hemodialisis. Dalam: Sudoyo, A.W.,
Setiyohadi, B., Alwi, I., Marcellus, S.K., Setiati, S., Buku Ajar Ilmu
Penyakit Dalam Jilid I. Edisi keempat. Jakarta: Pusat Penerbitan
Departemen Ilmu Penyakit Dalam FKUI, 579-580.

Roesli, R., 2008. Hipertensi, diabetes, dan gagal ginjal di Indonesia. Dalam:
Lubis, H.R., et al (eds). 2008. Hipertensi dan Ginjal. USU Press, Medan:
95-108.

Saliba, W., Antonios, S., Abdallah, J., 2010, Treatment Issuess in anemia of
Chronic Kidney Disease, J Com. (17);9.pp. 415-21.

Sastroasmoro. S, Ismael. S, 2002, Dasar-Dasar Metodologi PenelitianKlinis, Ed.

2, CV. Sagung Seto: Yogyakarta.

Schonder, K.S., 2008, Chronic & End Stage Renal Disease, in Dipiro,
J.T.,Chisholm-Burns, M.A., Wells, B.G., Schwinghammer, T.L., Malone,
P.M., Kolesar, J.M., Rotschafer, J.C. : Pharmacotherapy Principal
Practice, The McGraw-Hill Companies Inc., USA.

Schmid, H., Hartmann, B., Schiffl, H., 2009, Adherence to Prescribed Oral
Medication in Adult Patients Undergoing Chronic Hemodyalisis: A
Critical Review of The Literature, Eur J Med Ners,14:185-190.

Setyaningrum, N., 2013, Kajian DRPs dan Gambaran Kualitas Hidup Pasien
Hemodialisis Rutin Pasien Lanjut Usia di RSUP Dr. Sardjito Yogyakarta,
Tesis, Universitas Gadjah Mada:Yogyakarta.

Silbiger, S., Neugarten, J., 2008, Gender and Human Chronic Kidney Disease,
Gend Med; 5 suppl:53-58.

Soenarso,2004, Aspek Klinik Penyakit ginjal kronik,Fakultas Kedokteran

Unjani:Cimahi.

Smeltzer, Suzanne.,C,2001, Buku Ajar Keperawatan Medikal Bedah,

EGC:Jakarta.

Stevens, L., Wang, C., Hudary, C., Becker, B.N., dkk., 2010, Prevalence of
Chronic Kidney Disease and Comorbid Illness in Elderly Patients in The
United States; Results from The Kidney Early Evaluation Programs
(KEEP), Am Journ of Kidney Disease, vol 55(3),Suppl 2, march:pp 523-
533.

71
Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources,
consequences and therapy. Semin Dial 2002; 15:329–37.

Sukandar. E,2006, Gagal Ginjal dan Panduan Terapi Dialisis,Faklutas

Kedokteran UNPAD,Bandung.

Suwitra. K. 2006. Penyakit Ginjal Kronik. Dalam Sudoyo, A.W., dkk., Editor. Buku
Ajar Ilmu Penyakit Dalam. Jilid I. Edisi keempat. Penerbit Depertemen Ilmu
Penyakit Dalam FK-UI. Jakarta. Hal. 570-572.

Tambayong. Jan,2000,Patofisiologi dalam Keperawatan, EGC:Jakarta.

Tarif. N, Anemia Management in Patients with Chronic Renal Disease : Current

Recommendations. Saudi J Kidney Dis Transplant 2002 ; 13 : 331-335
Tong E,M., Nissenson. A.,R.,2001,Erythropoietin and anemia. Semin Nephrol;
21:190–203.

USRDS, 2011. Chapter Twelve : International

Comparisons.http://www.usrds.org/2011/view/v2_12.asp.

72